Sponsor:
Paul Szabolcs
Code:
NCT03500731
Conditions
Idiopathic Pulmonary Fibrosis
Emphysema or COPD
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
CD3/CD19 negative hematopoietic stem cells
Rituximab
Alemtuzumab
Fludarabine
Thiotepa
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations